Invention Grant
US08530478B2 Piperazine derivatives used as CAV2.2 calcium channel modulators
有权
哌嗪衍生物用作CAV2.2钙通道调节剂
- Patent Title: Piperazine derivatives used as CAV2.2 calcium channel modulators
- Patent Title (中): 哌嗪衍生物用作CAV2.2钙通道调节剂
-
Application No.: US13054265Application Date: 2009-07-15
-
Publication No.: US08530478B2Publication Date: 2013-09-10
- Inventor: Paul John Beswick , Alister Campbell , Andrew Peter Cridland , Robert James Gleave , Jag Paul Heer , Neville Hubert Nicholson , Lee William Page , Sadie Vile
- Applicant: Paul John Beswick , Alister Campbell , Andrew Peter Cridland , Robert James Gleave , Jag Paul Heer , Neville Hubert Nicholson , Lee William Page , Sadie Vile
- Applicant Address: GB London
- Assignee: Convergence Pharmaceuticals Limited
- Current Assignee: Convergence Pharmaceuticals Limited
- Current Assignee Address: GB London
- Agency: Womble Carlyle Sandridge & Rice, LLP
- Priority: GB0813142.7 20080717
- International Application: PCT/EP2009/059011 WO 20090715
- International Announcement: WO2010/007072 WO 20100121
- Main IPC: A61K31/496
- IPC: A61K31/496 ; C07D401/06
Abstract:
The present invention relates to novel piperazine derivatives (I); to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
Public/Granted literature
- US20110130379A1 PIPERAZINE DERIVATIVES USED AS CAV2.2 CALCIUM CHANNEL MODULATORS Public/Granted day:2011-06-02
Information query
IPC分类:
